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     Protein aggregation is a serious problem for both biotechnology and cell biology. Diseases such as prion 
misfolding, Alzheimer’s, and other amyloidosis are phenomena for which protein aggregation in our living 
cells is of considerable relevance. Human lysozyme has been shown to form amyloid fibrils in individuals 
suffering from nonneuropathic systemic amyloidosis, all of which have point mutations in the lysozyme 
gene. In this study, we investigated effect of small additives on the thermal aggregation of lysozyme. The 
main finding of this work is that multiple amine groups, spermine and spermidine, play pivotal roles in 
preventing the thermal aggregation of lysozyme. Our results showed that effect of spermine is more than 
spermidine.  
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INTRODUCTION 
     Protein aggregation is an unproductive 
phenomenon in biotechnology and cell living. To 
reduce aggregation in vitro, various techniques 
have been developed, such as the use of a 
molecular chaperone and protein mutagenesis, as 
well as control of pH, temperature, protein 
concentration, and ionic strength. A simple, 
practical approach to solving the aggregation 
problem is the utilization of small molecular 
additives that as aggregation suppressors. Many 
types of additive, such as guanidine [1, 2], proline 
[3], arginine[1, 4, 5], arginine ethylester [6], 
amino acid derivatives [7] have been reported.  
Human lysozyme has been shown to form  
amyloid fibrils in individuals suffering from 
nonneuropathic  systemic amyloidosis, all of 
which have point mutations in the lysozyme gene 
[8-10]. The individuals affected are heterozygous 
for the  mutation and carry amyloid deposits in 
different  tissues containing the variant but not 
wild-type  lysozyme [11]. The formation of 
amyloid deposits is usually slow, but is generally 
fatal by the fifth decade of life. The only effective 
treatment at present  involves transplantation of 
damaged organs, such  as kidneys, when amyloid 
deposition causes their  malfunction [11]. The 
properties of two amyloidogenic lysozyme  
 
mutants (I56T and D67H) have  been studied in 
detail and, when compared to  those of the wild-
type protein, the mutants were  found to have 
reduced structural stability and  altered folding 
kinetics [12-14]. Polyamines are highly regulated 
polycations that are essentially involved in cell 
growth and differentiation. They are organic 
aliphatic cations with two (putrescine), three 
(spermidine) or four (spermine) amino groups that 
are fully protonated at physiologic pH [15, 16]. 
Various physiological roles were suggested for 
polyamines. For example: regulator of 
transcriptional and translational stages of protein 
synthesis, stabilizer of membranes, modulation of 
neurophysiologic functions, intracellular 
messengers, free radical scavenger, quencher of 
chemically generated singlet oxygen, protection 
of biomacromolecules from reactive oxygen 
species and metal chelator [15-21]. The protective 
role of polyamines on core histones, ubiquitin, 
antithrombin III, plasminogen, Hb and some other 
proteins against glycation was also demonstrated 
[17, 22]. Also, it was shown that polyamines in 
high concentration (100mM) prevent thermal 
aggregation of proteins [23].  
In the present study, we have analyzed the 
formation of amyloid fibrils by HEVL, as this 
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protein is readily available and represents an 
excellent experimental system through which to 
study the determinants of protein aggregation, 
being highly homologous to human lysozyme in 
structure, although only 40% identical in its 
sequence [24]. The purpose of this study is to 
evaluate the effect of polyamines, as chemical 
chaperon, on aggregation of lysozyme in aqueous 
buffer solutions. 
 
MATERIAL AND METHODS 
Materials  
   Chicken egg white lysozyme (L7651), 
spermidine trihydrochloride (S2501) and 
spermine tetrahydrochloride (S2876) were 
purchased from Sigma Chemical Co., New York, 
USA. Micrococcus lysodeikticus ATCC No. 4698 
(M3770) as the LZ substrate was bought from 
Sigma Co., Koln, Germany. Other used materials 
were of analytical grade. 
Enzymatic activity  
The enzymatic activity of lysozyme in presence 
polyamines was estimated by the turbidimetric 
assay method. Lysozyme activity was measured 
by mixing 20-μl aliquots of lysozyme solution 
(0.1 mg/ml) with 0.980 ml of a M. lysodeikticus 
solution (0.2 mg/ml), as substrate, and polyamines 
(1mM), as additive, in pH 6.2, 66 mM sodium 
phosphate, equilibrated at 25 °C. The samples 
were mixed by repeatedly inverting the cuvette 
for 15 s. The decrease in the light scattering 
intensity of the solution was monitored by 
absorbance at 450 nm. The residual activity was 
estimated by fitting the data through linear 
extrapolation. One unit of activity corresponds to 
an absorbance decrease of 0.0026/min. The 
concentrations of lysozyme were measured by 
absorbance at 280 nm using extinction 









 for the reduced/denatured form 
[25].  
Heat-induced aggregation of lysozyme  
Heat-induced aggregates of lysozyme were 
quantified as follows. Solutions, containing 
various concentrations (0.1-0.7 mg/ml) of 
lysozyme in 66 mM sodium-phosphate buffer (pH 
6.2) and 1mM additive were prepared. After heat 
treatment at 98 °C, the samples were centrifuged 
at 15 000 g for 20 min [23]. The protein 
concentration of supernatants was determined by 
Bradford colorimetric method [26], the amount of 
aggregates was calculated by subtraction 
concentration protein after and before heat 
treatment at 98 °C. 
Native electrophoresis analysis 
Native PAGE was performed using a system of a 
10-20% gradient polyacrylamide gel for the Heat-
induced aggregates of lysozyme (1 mg/ml) in 
presence and absent various concentrations 
additive in 66 mM sodium-phosphate buffer. 
After electrophoresis, the gels were stained with 
Coomassie Brilliant Blue G-250. 
 
RESULTS 
Heat-induced aggregation  
    After heating and then centrifuge the various 
concentrations of protein, solvated protein 
concentrations of supernatant were determined by 
Bradford method. 
The amounts of aggregations were calculated by 
subtraction of concentration solvated protein 
before and after heat treatment at 98 °C (Fig. 1). 
Fig. 2, 3 show activity & specific activity of 
lysozyme before and after heat treatment. Because 
of decreasing of the specific activity of lysozyme 
after treatment of heat, we supposed there are 
molecules of protein in the solution, but they are 
inactive (unfolded lysozyme). Amount of 
unfolded lysozyme was calculated by subtraction 
specific activity before and after treatment of heat 
(Fig. 4). 
Native electrophoresis 
PAGE electrophoresis showed that smears 
appeared with different electrophoretic mobilities 
(dimmer, trimmer, …). In comparison with Sp (1-
10 mM/ml) the amounts of smears were more in 
the presence of Sd (1-20 mM/ml). But in high 
concentrations of polyamines (Sp > 10mg/ml; Sd 
> 20mg/ml) no smears or aggregations were 
observed (Fig. 6, 7). Native electrophoresis 
analysis lysozyme samples shows that spermine 
and spermidine decrease intermediate of 
molecules (unfold, dimmer and trimmer, …) 
between aggregate form and native form. In the 
presence of 50 mM spermidine or spermine, no 
intermediate of molecule was observed at the 
protein concentration of (1 mg/ml), and was 
observed that reversible of aggregation in the 
presence of polyamines after a week (Fig. 6B, 7B)
 





Figure 1. Thermal aggregation of lysozyme in the presence of polyamines. The samples contaning 0.1-0.7 mg/ml lysozyme in the 
presence 1 mM polyamines at pH 6.2 were heated at 98 oC for the 30 min. closed squares, lysozyme alone; opened squared, LZ in 
the presence of Sd; opened triangles, LZ in the presence of Sp. 
 
 
Figure 2. Activity of lysozyme before and after heating. The decrease of activity of lysozyme after treatment of heat was observed. 




Figure 3. Specific activity of lysozyme before and after heating. The deacrease of specific activity of lysozyme after treatment of 
heat was observed. Before thermal; closed squared, after thermal; closed triangles. 
 
 
Figure 4. Unfolded lysozyme. Amount of unfolded of lysozyme was calculated by subtraction specific activity before and after 
treatment of heat. The same samples described in Fig. 1. 
 






Figure 5. PAGE electrophoresis of lysozyme in the presence 
or absence of polyamines before treatment of heating. 1: 
LZ+1mM of Sp, 2: LZ+5mM of Sp, 3: LZ+10 mM of Sp, 4: 
LZ+20 mM of Sp, 5: LZ+100 mM of Sp, 6: LZ alone, 7: 
LZ+5 mM of Sd, 8: LZ+10 mM of Sd, 9: LZ+20 mM of Sd, 






Figure 6. PAGE electrophoresis of lysozyme in the presence 
of spermidine after treatment of heating. (A) 1: LZ before 
treatment of heating, 2: LZ alone, 3: LZ+1 mM, 4: LZ +10 
mM, 5: LZ+20 mM, 6: LZ+30 mM, 7: LZ+40 mM, 8: LZ+50 
mM of spermidine. (B) The same samples described in (A) 






Figure 7. PAGE electrophoresis of lysozyme in the presence 
of spermine after treatment of heating. (A) The same samples 
described in Fig. 6. (B) The same samples described in (A) 
after a week. 
 
DISCUSSION 
     Despite major efforts aimed at elucidating the 
genetic, cellular, and biochemical basis of 
amyloid diseases, relatively little is known in 
detail about the process that leads to the 
conversion of a soluble protein into a 
conformation that ultimately gives rise to its 
deposition in a living system. Amyloid diseases 
are of great clinical importance, and amyloid 
fibrils or their precursors (globular aggregates or 
protofibrils) have been implicated as primary 
causes of cell death and tissue degeneration in 
several such diseases [27-32]. Understanding the 
formation of amyloidogenic conformations of 
proteins and the mechanisms of aggregation may 
lead to novel therapeutic approaches to prevent or 
reverse the formation of amyloid structures in 
disease states. In this study, we investigated the 
basis of small additives that prevent the thermal 
aggregation of lysozyme. The main finding of this 
work is that multiple amine groups play pivotal 
roles in preventing the thermal aggregation of 
lysozyme.  
The obtained results demonstrate that exposure of 
lysozyme to polyamines causes the decrease in 
concentration of unfolded protein which is shown 
in figures 4, 6A, 7A.  
PAGE electrophoresis showed that smears 
appeared with different electrophoretic mobilities 
(dimmer, trimmer and so on). In comparison with 
Sp (1-10 mM/ml) the amount of smears were 
more in the presence of Sd (1-20 mM/ml). But in 
high concentrations of polyamines (Sp > 
10mg/ml; Sd > 20mg/ml) no smears or 
aggregations were observed. These results 
illustrated in low concentration of polyamines that 
unfolded proteins decreased than lysozyme alone 
(Fig. 4). Also, our results in the case of PAGE 
electrophoresis showed that aggregates in the 
presence of polyamines are reversible (Fig. 6B, 
7B).  
Motonori Kudou et al.[23]shown after heat 
treatment at 98 
o
C for 30 min, no aggregates were 
observed in the presence of 100 mM spermidine 
or spermine , while 50% of the molecules were 
inactivated. Mañas et al. [33] showed that in 
lysozyme along a thermal treatment in higher 
temperature (89 
o
C) sulfhydryl radicals are 
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generated from the beginning. Probably the 
decrease in activity after long heating times due to 
the occurrence of secondary reactions such as 
intermolecular aggregation or formation new 
disulphide bonds. . Motonori Kudou et al. [23] 
shown by thermal CD that at temperatures above 
84
 o
C, lysozyme was fully unfolded by heating. 
Likely in this temperature the enzyme would lose 
its catalytic activity by the action of heat with 
disulfide bond breakage and was disturbed 
secondary structure. Some research has reported 
that the heat inactivation of proteins is caused by 
both noncovalent and covalent modifications, 
including disulfide exchanges [34], -elimination 
of disulfide bonds [35]. 
These facts propose the following mechanism, 
whereby the heat-induced aggregation of 
lysozyme is considered to follow three steps at 
high temperatures: 
N1 )1(  N2  )2(  U  3  Agg 
Where, N1 represents the native molecule, N2 
represents the like of native molecule but 
decreased activity (they aren’t shown in 
electrophoresis), U represents the denatured 
molecules which are soluble (unfolded protein) 
and Agg represents the insoluble aggregates. 
Under Eqn (1), weakness binds (such as hydrogen 
and hydrophobic bonds) cleavages, Under Eqn (2) 
strong bond (such as disulfide) breakage. Sp and 
Sd prevent the intermolecular interactions shown 
in Eqn (2). Also, it was reported that polyamines 
directly bind to LZ [36]. Therefore, this 
interaction induces more positive charges on 
protein. Thus, it leading to increased electrostatic 
repulsion and a reduction of intermolecular 
interaction, in this respect Sp with four amino 
groups is more powerful than Sd with three amine 
groups. Likely polyamines interact with N2 form 
of lysozyme. This finding is expected to initiate 
further analysis of the additive that prevents the 
thermal aggregation of protein.  
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